1. Home
  2. Labeler Index
  3. Genentech, Inc.
  4. 50242-082
  5. NDC Package Code: 50242-082-03 Lucentis

NDC Package 50242-082-03 Lucentis

Ranibizumab Injection, Solution Intravitreal - View Billable Units, 11-Digit Format, RxNorm

Table of Contents

    1. Package Information
    2. NDC HCPCS Crosswalk
    3. Other Packages
    4. Frequently Asked Questions

Package Information

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
50242-082-03
Package Description:
1 SYRINGE, GLASS in 1 CARTON / .05 mL in 1 SYRINGE, GLASS
Product Code:
50242-082
Proprietary Name:
Lucentis
Non-Proprietary Name:
Ranibizumab
Substance Name:
Ranibizumab
Usage Information:
This medication is used to treat certain serious eye conditions (such as age-related macular degeneration, macular edema, diabetic retinopathy). It is used to help prevent decreased vision and blindness. Ranibizumab works by slowing the growth of abnormal new blood vessels in the eye and decreasing leakage from these blood vessels.
11-Digit NDC Billing Format:
50242008203
Billing Unit:
ML - Billing unit of "milliliter" is used when a product is measured by its liquid volume.
NDC to RxNorm Crosswalk:
  • RxCUI: 1864423 - ranibizumab 0.5 MG in 0.05 ML Prefilled Syringe
  • RxCUI: 1864423 - 0.05 ML ranibizumab 10 MG/ML Prefilled Syringe
  • RxCUI: 1864423 - ranibizumab 0.5 MG per 0.05 ML Prefilled Syringe
  • RxCUI: 1864425 - Lucentis 0.5 MG in 0.05 ML Prefilled Syringe
  • RxCUI: 1864425 - 0.05 ML ranibizumab 10 MG/ML Prefilled Syringe [Lucentis]
    • Product Type:
    Human Prescription Drug
    Labeler Name:
    Genentech, Inc.
    Dosage Form:
    Injection, Solution - A liquid preparation containing one or more drug substances dissolved in a suitable solvent or mixture of mutually miscible solvents that is suitable for injection.
    Administration Route(s):
  • Intravitreal - Administration within the vitreous body of the eye.
    • Active Ingredient(s):
  • RANIBIZUMAB 6 mg/mL
    • Pharmacologic Class(es):
  • Vascular Endothelial Growth Factor Inhibitor - [EPC] (Established Pharmacologic Class)
  • Vascular Endothelial Growth Factor Inhibitors - [MoA] (Mechanism of Action)
    • Sample Package:
    No
    FDA Application Number:
    BLA125156
    Marketing Category:
    BLA - A product marketed under an approved Biologic License Application.
    Start Marketing Date:
    08-10-2012
    Listing Expiration Date:
    12-31-2025
    Exclude Flag:
    N
    Code Structure:

    The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

    * Please review the disclaimer below.

    NDC HCPCS Crosswalk

    This crosswalk is intended to help the public understand which drug products (identified by NDCs) are assigned to which HCPCS billing codes.

    NDC 50242-082-03 HCPCS crosswalk information with package details and bill units information.

    NDC Billing CodeHCPCS CodeHCPCS Code Desc.DosagePackage SizePackage QuantityBillable UnitsBillable Units / Pkg
    50242008203J2778Ranibizumab injection0.1 MG0.05133

    * Please review the disclaimer below.

    Other Product Packages

    The following packages are also available for this product:

    NDC Package CodePackage Description
    50242-082-881 SYRINGE, GLASS in 1 CARTON / .05 mL in 1 SYRINGE, GLASS

    * Please review the disclaimer below.

    Frequently Asked Questions

    What is NDC 50242-082-03?

    The NDC Packaged Code 50242-082-03 is assigned to a package of 1 syringe, glass in 1 carton / .05 ml in 1 syringe, glass of Lucentis, a human prescription drug labeled by Genentech, Inc.. The product's dosage form is injection, solution and is administered via intravitreal form.

    Is NDC 50242-082 included in the NDC Directory?

    Yes, Lucentis with product code 50242-082 is active and included in the NDC Directory. The product was first marketed by Genentech, Inc. on August 10, 2012 and its listing in the NDC Directory is set to expire on December 31, 2025 if the product is not updated or renewed by the manufacturer.

    What is the NDC billing unit for package 50242-082-03?

    The contents of this package are billed per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume.

    What is the 11-digit format for NDC 50242-082-03?

    The 11-digit format is 50242008203. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

    This package code is originally configured in a 5-3-2 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

    10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
    5-3-250242-082-035-4-250242-0082-03